KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 60 filers reported holding KALA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $571,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vahanian & Associates Financial Planning Inc. | 181,384 | $54,000 | 0.23% |
| Samsara BioCapital, LLC | 601,162 | $180,000 | 0.05% |
| Board of Trustees of The Leland Stanford Junior University | 688,701 | $207,000 | 0.01% |
| Matisse Capital | 36,800 | $11,000 | 0.01% |
| Knights of Columbus Asset Advisors LLC | 120,841 | $36,000 | 0.00% |
| Covestor Ltd | 11,972 | $4,000 | 0.00% |
| Ergoteles LLC | 219,461 | $66,000 | 0.00% |
| Virtu Financial LLC | 74,636 | $22,000 | 0.00% |
| IPG Investment Advisors LLC | 14,300 | $4,000 | 0.00% |
| Aquatic Capital Management LLC | 13,200 | $4,000 | 0.00% |